This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept

PATH Resources

Our online catalog indexes publications, presentations, and related resources for peers in our field.

152 Resources
152 Resources
152 Resources
    Date
  1. The primary objective of this review is to summarize and assess the current evidence that could support a change to a single-dose schedule of HPV vaccine. The review also aims to identify gaps that remain in determining whether a single dose could be sufficiently protective to have a major impact against HPV infection and its sequelae, within the context of immunization programs.
    Published: May 2022
    Type: Resource Page
  2. This is the first resource in a project to develop a supply chain roadmap of vaccine manufacturing in Africa. The project seeks to quantify the gap between today's capacity and desired future capacity to support the Partnerships for African Vaccine Manufacturing Framework for Action, which sets the goal of manufacturing 60 percent of Africa's routine immunization needs on the continent by 2040.This map identifies existing African vaccine manufacturers and their capabilities, as well as provides an initial analysis and conclusions about the current African vaccine manufacturing landscape. This map can be used by national governments, pharmaceutical industry partners, philanthropic foundations, private sector organizations, and others to inform them of the current state of manufacturing and guide their plans for the future.
    Published: May 2022
    Type: Resource Page
  3. In 2020, Ghana switched from using ROTARIX® to ROTAVAC® in its national immunization program. PATH worked with Ghana Health Service and the University of Ghana to analyze the economic implications of this switch. These four fact sheets explore the key results of these analyses, collectively providing a case study on Ghana’s rotavirus vaccine product switch.(Manuscript pending submission to a peer-reviewed journal.)
    Published: May 2022
    Type: Resource Page
  4. The World Health Organization’s (WHO) Strategic Advisory Group of Experts (SAGE) on Immunization concluded that a single dose of human papillomavirus (HPV) vaccine delivers solid protection against HPV. Based on the available evidence, SAGE advised that countries may now choose between a one- or two-dose schedule for 9–14-year-old girls and women aged 15 to 20. This is a major step toward reaching the WHO’s global strategy to accelerate the elimination of cervical cancer.The following resource provides background on HPV and cervical cancer, HPV vaccines, and the current evidence and potential impact for a single-dose regimen.
    Published: April 2022
    Type: Resource Page
  5. The COVID-19 Maternal Immunization Resource Library is a one-stop information hub linking to global and country-specific research, guidance, tools, publications, and other resources related to COVID-19 vaccines and pregnancy and/or breastfeeding. The tool is designed to support decision-makers, implementers, funders, advocates, and others working to advance COVID-19 maternal immunization by connecting them to the latest information on research, safety registries, vaccine safety and acceptance, pregnancy outcomes, and other topics. Information will be useful for stakeholders across vaccine; maternal, newborn, and child health; and other public health fields.
    Published: April 2022
    Type: Resource Page
Load more